RxDoctor Payments Data

Peggy Isaac

Nurse Practitioner · Russellville, ARNPI 1922719806

Payments from drug & device makers

$922in general payments, 2019–2025

Across 41 payments — averaging $22.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$160
  • Dendreon Pharmaceuticals LLC$113
  • Antares Pharma, Inc.$101
  • Endo Pharmaceuticals Inc.$85
  • Tolmar, Inc.$78
  • Sumitomo Pharma America, Inc.$71
  • plus $313 from 12 others

What the payments were for

  • Food & beverage$922100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$922 in reported general payments places this provider in the 70th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas

Medicare billing

Part B allowed, 2024
$286,448
Medicare patients
756
Services billed
8,633

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
GemtesaVibegron286$165,724
MyrbetriqMirabegron102$52,002
Tamsulosin Hcl709$9,008
Solifenacin Succinate106$5,794
Trospium Chloride73$4,072
Estradiol57$3,743
Methenamine Hippurate67$3,564
Finasteride289$2,796
Dutasteride102$2,651
Terazosin Hcl100$2,468
Testosterone15$2,253
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst82$2,216
Oxybutynin Chloride ErOxybutynin Chloride81$1,447
Tolterodine Tartrate ErTolterodine Tartrate22$1,234
Tolterodine Tartrate12$1,093

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Sumitomo Pharma America, Inc.Gemtesa$71$165,724286 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 697 nurse practitioner providers in Arkansas.

Other nurse practitioner in Russellville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →